What is NDC 85766-070?

85766-070 is the product NDC for Celestone Soluspan, Betamethasone acetate 3 mg/mL; Betamethasone sodium phosphate 3 mg/mL injection, suspension, listed with the FDA by Sportpharm LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Celestone Soluspan (Betamethasone Acetate and Betamethasone Sodium Phosphate).

What is the active ingredient?

Betamethasone acetate, Betamethasone sodium phosphate.

Sportpharm LLC, NDC labeler code 85766. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Celestone Soluspan?

1 other product NDC are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Celestone Soluspan NDC 85766-070 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)85766-070Labeler and product segments. Claims need a package NDC.

Product NDC at billing width85766-0070Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
85766-070-05	85766007005	1 VIAL, MULTI-DOSE in 1 BOX (85766-070-05) / 5 mL in 1 VIAL, MULTI-DOSEMarketed from Oct 1, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Celestone Soluspan
Generic name (nonproprietary): betamethasone acetate and betamethasone sodium phosphate
Active ingredients: Betamethasone acetate — 3 mg/mLBetamethasone sodium phosphate — 3 mg/mL
Dosage form: Injection, Suspension
Route: Intra-articular, Intralesional, Intramuscular, Soft tissue
Labeler: Sportpharm LLCNDC labeler code 85766
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 014602
Marketing start: Jun 1, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 85766-070_502f3a8b-e971-c921-e063-6294a90ae933SPL ID 502f3a8b-e971-c921-e063-6294a90ae933SPL set ID 95a19c2f-c329-4ce1-a0a7-174814aac3adRxCUI 578803, 578806UNII TI05AO53L7, 7BK02SCL3W
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N485766007005 followed by a unit qualifier and the quantity

Package 85766-0070-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 24, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE When oral therapy is not feasible, the intramuscular use of CELESTONE ® SOLUSPAN ® Injectable Suspension is indicated as follows: Allergic States Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic Diseases Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome). Endocrine Disorders Congenital adrenal hyperplasia, hypercalcemia associated with cancer,…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 85766-070

What is NDC 85766-070?: 85766-070 is the product NDC for Celestone Soluspan, Betamethasone acetate 3 mg/mL; Betamethasone sodium phosphate 3 mg/mL injection, suspension, listed with the FDA by Sportpharm LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Celestone Soluspan (Betamethasone Acetate and Betamethasone Sodium Phosphate).
What is the active ingredient?: Betamethasone acetate, Betamethasone sodium phosphate.
Who is the labeler?: Sportpharm LLC, NDC labeler code 85766. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Celestone Soluspan?: 1 other product NDC are listed under this name. See all Celestone Soluspan NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Celestone Soluspan NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Celestone Soluspanbetamethasone acetate and betamethasone sodium phosphate	Betamethasone acetate 3 mg/mL; Betamethasone sodium phosphate 3 mg/mL	Injection, SuspensionIntra-articular, Intralesional, Intramuscular, Soft tissue	Organon LLC	78206-118	78206-0118-01

Other NDCs under NDA 014602

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 014602
Product	Strength	Form · route	Labeler	Product NDC
Celestone Soluspanbetamethasone acetate and betamethasone sodium phosphate	Betamethasone acetate 3 mg/mL; Betamethasone sodium phosphate 3 mg/mL	Injection, SuspensionIntra-articular, Intralesional, Intramuscular, Soft tissue	Organon LLC	78206-118